Tailored treatment shows promise for slowing early dementia

NCT ID NCT05894954

Completed Disease control Sponsor: Alzheimer's Prevention and Reversal Project, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a personalized treatment plan—based on each person's test results—works better than standard care for people with mild cognitive impairment or early-stage dementia. 73 adults aged 45-76 took part, receiving either the tailored plan or usual care for 9 months. The goal was to see if the personalized approach improves memory and thinking more than standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA, MILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia follicular lymphoma nominal aphasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEMENTIA, MILD MILD COGNITIVE IMPAIRMENT

Contacts and locations

Locations

Ann Hathaway, MD

San Rafael, California, 94903, United States
Bay Area Wellness

Walnut Creek, California, 94597, United States
Kemper Cognitive Wellness

Rocky River, Ohio, 44116, United States
MaxWell Clinic, PLC

Brentwood, Tennessee, 37027, United States
Rezilir Health

Hollywood, Florida, 33020, United States
True Health Center for Functional Medicine

Folsom, California, 95630, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.